FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway Journal Article


Authors: Gulbins, E.; Bissonnette, R.; Mahboubi, A.; Martin, S.; Nishloka, W.; Brunner, T.; Baier, G.; Baler-Bltterlich, G.; Byrd, C.; Lang, F.; Kolesnick, R.; Altman, A.; Green, D.
Article Title: FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
Abstract: Fas receptor-induced apoptosis plays critical roles in immune homeostasis. However, most of the signal transduction events distal to Fas ligatlon have not been elucidated. Here, we show that Ras is activated following ligation of Fas on lymphoid lines. The activation of Ras is a critical component of this apoptotic pathway, since Inhibition of Ras by neutralizing antibody or a dominant-negative Ras mutant interfered with Fas-induced apoptosis. Furthermore, ligatlon of Fas also resulted in stimulation of the sphingomyelin signaling pathway to produce ceramides, which, in turn, are capable of inducing both Ras activation and apoptosis. This suggests that ceramides acts as second messengers in Fas signaling via Ras. Thus, ligation of the Fas molecule on lymphocyte lines induces activation of Ras via the action of ceramide, and this activation is necessary, but not sufficient, for subsequent apoptosis. © 1995.
Keywords: signal transduction; leukemia; nonhuman; t lymphocyte; t-lymphocytes; animal cell; mouse; animal; mice; apoptosis; fas antigen; tumor cells, cultured; monoclonal antibody; leukemia cell; oncogene ras; antigens, surface; ceramide; ceramides; sphingomyelin; second messenger; antigens, cd95; second messenger systems; human; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; proto-oncogene protein p21(ras)
Journal Title: Immunity
Volume: 2
Issue: 4
ISSN: 1074-7613
Publisher: Cell Press  
Date Published: 1995-04-01
Start Page: 341
End Page: 351
Language: English
DOI: 10.1016/1074-7613(95)90142-6
PUBMED: 7536620
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 28 August 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard N Kolesnick
    299 Kolesnick